Outcomes with lower intensity therapy in TP53-mutated acute myeloid leukemia

Prajwal Boddu, Hagop Kantarjian, Farhad Ravandi, Guillermo Garcia-Manero, Gautam Borthakur, Michael Andreeff, Elias J. Jabbour, Christopher B. Benton, Courtney D. DiNardo, Marina Konopleva, Naval Daver, Keyur Patel, Koichi Takahashi, Rashmi Kanagal-Shamanna, Jorge Cortes, Tapan Kadia

Research output: Contribution to journalLetter

2 Scopus citations
Original languageEnglish (US)
Pages (from-to)2238-2241
Number of pages4
JournalLeukemia and Lymphoma
Volume59
Issue number9
DOIs
StatePublished - Sep 2 2018

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Boddu, P., Kantarjian, H., Ravandi, F., Garcia-Manero, G., Borthakur, G., Andreeff, M., Jabbour, E. J., Benton, C. B., DiNardo, C. D., Konopleva, M., Daver, N., Patel, K., Takahashi, K., Kanagal-Shamanna, R., Cortes, J., & Kadia, T. (2018). Outcomes with lower intensity therapy in TP53-mutated acute myeloid leukemia. Leukemia and Lymphoma, 59(9), 2238-2241. https://doi.org/10.1080/10428194.2017.1422864